European Case Law Identifier: | ECLI:EP:BA:2015:T182511.20150714 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 14 July 2015 | ||||||||
Case number: | T 1825/11 | ||||||||
Application number: | 06805884.1 | ||||||||
IPC class: | C07K 16/26 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | Antibodies against 25-Hydroxyvitamin D | ||||||||
Applicant name: | Roche Diagnostics GmbH F.Hoffmann-La Roche AG |
||||||||
Opponent name: | BioMérieux Immunodiagnostic Systems Limited Abbott Laboratories Immundiagnostik AG |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Lapse of patent in all designated states - termination of appeal proceedings | ||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111825eu1.html
Date retrieved: 17 May 2021
8 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Implementing Rules
XR.84 EPC Continuation of the opposition proceedings by the European Patent Office of its own motion